Strata Critical Medical, Inc. (SRTA) vs Starling Oncology, Inc. (STLN)
Strata Critical Medical, Inc. and Starling Oncology, Inc. are both Medical Care Facilities companies. Starling Oncology, Inc. is the larger, with a market value of $650.9M against $476.8M — 1.4× the size. Starling Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Strata Critical Medical, Inc. trades at 10.5×. Strata Critical Medical, Inc. grew revenue faster over the last twelve months: 136.1% against 38.4%. Strata Critical Medical, Inc. has the higher net margin (15.7% vs −6.18%) and the higher return on invested capital (−4.98% vs −117.7%). Across the 17 metrics below, Strata Critical Medical, Inc. leads on 9 and Starling Oncology, Inc. on 8.
Valuation
Profitability
| Metric | SRTA | STLN | Medical Care Facilities median |
|---|---|---|---|
| Gross margin | 21.25% | 15.69% | 30.78% |
| Operating margin | (7.97%) | (4.44%) | 5.74% |
| Net margin | 15.71% | (6.18%) | 2.32% |
| Free cash flow margin | (19.34%) | (0.56%) | 5.46% |
| Return on equity | 16.01% | 214.12% | 8.76% |
| Return on assets | 13.62% | (21.47%) | 2.18% |
| Return on invested capital | (4.98%) | (117.66%) | 5.40% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack